chr12-865122-C-T

Variant summary

Our verdict is Likely benign. The variant received -1 ACMG points: 0P and 1B. BP4

The NM_213655.5(WNK1):​c.2152C>T​(p.Arg718Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000323 in 1,519,106 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 9/14 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R718H) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000034 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000032 ( 0 hom. )

Consequence

WNK1
NM_213655.5 missense

Scores

4
8

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:1U:4

Conservation

PhyloP100: 3.09

Publications

2 publications found
Variant links:
Genes affected
WNK1 (HGNC:14540): (WNK lysine deficient protein kinase 1) This gene encodes a member of the WNK subfamily of serine/threonine protein kinases. The encoded protein may be a key regulator of blood pressure by controlling the transport of sodium and chloride ions. Mutations in this gene have been associated with pseudohypoaldosteronism type II and hereditary sensory neuropathy type II. Alternatively spliced transcript variants encoding different isoforms have been described but the full-length nature of all of them has yet to be determined.[provided by RefSeq, May 2010]
WNK1 Gene-Disease associations (from GenCC):
  • neuropathy, hereditary sensory and autonomic, type 2A
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P, Ambry Genetics
  • pseudohypoaldosteronism type 2C
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • hereditary sensory and autonomic neuropathy type 2
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -1 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.3321278).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
WNK1NM_213655.5 linkc.2152C>T p.Arg718Cys missense_variant Exon 9 of 28 ENST00000340908.9 NP_998820.3 Q9H4A3-5
WNK1NM_018979.4 linkc.2139+2852C>T intron_variant Intron 8 of 27 ENST00000315939.11 NP_061852.3 Q9H4A3-1A5D8Z4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
WNK1ENST00000340908.9 linkc.2152C>T p.Arg718Cys missense_variant Exon 9 of 28 5 NM_213655.5 ENSP00000341292.5 Q9H4A3-5
WNK1ENST00000315939.11 linkc.2139+2852C>T intron_variant Intron 8 of 27 1 NM_018979.4 ENSP00000313059.6 Q9H4A3-1

Frequencies

GnomAD3 genomes
AF:
0.0000341
AC:
5
AN:
146764
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000499
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000679
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000305
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000490
AC:
6
AN:
122564
AF XY:
0.0000452
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000130
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000422
Gnomad OTH exome
AF:
0.000267
GnomAD4 exome
AF:
0.0000321
AC:
44
AN:
1372342
Hom.:
0
Cov.:
30
AF XY:
0.0000326
AC XY:
22
AN XY:
675438
show subpopulations
African (AFR)
AF:
0.0000637
AC:
2
AN:
31408
American (AMR)
AF:
0.000114
AC:
4
AN:
35096
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24574
East Asian (EAS)
AF:
0.0000563
AC:
2
AN:
35526
South Asian (SAS)
AF:
0.0000129
AC:
1
AN:
77788
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
33484
Middle Eastern (MID)
AF:
0.000355
AC:
2
AN:
5638
European-Non Finnish (NFE)
AF:
0.0000280
AC:
30
AN:
1071392
Other (OTH)
AF:
0.0000522
AC:
3
AN:
57436
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
3
6
8
11
14
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000341
AC:
5
AN:
146764
Hom.:
0
Cov.:
32
AF XY:
0.0000279
AC XY:
2
AN XY:
71682
show subpopulations
African (AFR)
AF:
0.0000499
AC:
2
AN:
40098
American (AMR)
AF:
0.0000679
AC:
1
AN:
14732
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3254
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5138
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4640
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10158
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
300
European-Non Finnish (NFE)
AF:
0.0000305
AC:
2
AN:
65620
Other (OTH)
AF:
0.00
AC:
0
AN:
1974
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000944
Hom.:
1
Bravo
AF:
0.0000529
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:4
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Pathogenic:1Uncertain:1
-
Genomic Medicine Center of Excellence, King Faisal Specialist Hospital and Research Centre
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:research

- -

Oct 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

WNK1: PM2, BP4 -

Pseudohypoaldosteronism type 2C;C2752089:Neuropathy, hereditary sensory and autonomic, type 2A Uncertain:2
Jan 11, 2022
Fulgent Genetics, Fulgent Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 11, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 718 of the WNK1 protein (p.Arg718Cys). This variant is present in population databases (rs786205473, gnomAD 0.01%). This missense change has been observed in individual(s) with limb-girdle weakness (PMID: 27671536). ClinVar contains an entry for this variant (Variation ID: 191028). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt WNK1 protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Inborn genetic diseases Uncertain:1
Mar 24, 2022
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.R718C variant (also known as c.2152C>T), located in coding exon 9 of the WNK1 gene, results from a C to T substitution at nucleotide position 2152. The arginine at codon 718 is replaced by cysteine, an amino acid with highly dissimilar properties. This alteration has been detected in an individual with limb-girdle muscular dystrophy (Monies D et al. Hum Genomics, 2016 Sep;10:32). This amino acid position is well conserved in available vertebrate species; however, cysteine is the reference amino acid in other vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.14
T
BayesDel_noAF
Benign
-0.20
CADD
Benign
20
DANN
Uncertain
1.0
Eigen
Uncertain
0.24
Eigen_PC
Uncertain
0.30
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Benign
0.70
T
M_CAP
Benign
0.011
T
MetaRNN
Benign
0.33
T
MetaSVM
Benign
-1.1
T
PhyloP100
3.1
Sift4G
Benign
0.076
T
Vest4
0.46
MVP
0.15
ClinPred
0.82
D
GERP RS
3.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
gMVP
0.027
Mutation Taster
=88/12
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs786205473; hg19: chr12-974288; COSMIC: COSV108138475; COSMIC: COSV108138475; API